Driving impairment
This medicine may affect your ability to drive or use machines.
Medicine information VERTIGIX 20mg / 40mg tablets
- Product code:
- W64195001
- Quantity:
- 50
- Indicated for:
- vertigo; vestibular disorders
- Route of administration:
- oral
- Substance:
- cinnarizine + dimenhydrinate (antihistamine+antiemetic)
- ATC
- N07CA52 — Nervous system | Antivertigo preparations
The combination of cinnarizine and dimenhydrinate is used for the treatment and prevention of balance disorders and associated symptoms such as dizziness, vertigo, nausea, and vomiting. It is commonly prescribed for vestibular conditions such as Ménière's disease or vertigo of central or peripheral origin.
Cinnarizine is a calcium channel blocker that improves blood circulation in the inner ear and reduces vestibular overstimulation. Dimenhydrinate is an antihistamine with antiemetic properties that reduces nausea and vomiting by blocking H1 receptors.
This combination is effective in relieving vertigo and nausea symptoms, providing a synergistic effect: cinnarizine addresses the cause of dizziness, while dimenhydrinate alleviates associated symptoms like nausea. It is recommended for both acute episodes and their prevention.
Side effects may include drowsiness, dry mouth, fatigue, headache, or gastrointestinal disturbances. In rare cases, allergic reactions, tremors, or confusion may occur, especially in elderly patients. Patients should avoid alcohol or other sedatives during treatment, as these may enhance drowsiness.
Patients should strictly follow their doctor’s instructions regarding dosage and treatment duration. It is also advised not to drive or operate heavy machinery while using this medication due to the risk of drowsiness.
Cinnarizine is a calcium channel blocker that improves blood circulation in the inner ear and reduces vestibular overstimulation. Dimenhydrinate is an antihistamine with antiemetic properties that reduces nausea and vomiting by blocking H1 receptors.
This combination is effective in relieving vertigo and nausea symptoms, providing a synergistic effect: cinnarizine addresses the cause of dizziness, while dimenhydrinate alleviates associated symptoms like nausea. It is recommended for both acute episodes and their prevention.
Side effects may include drowsiness, dry mouth, fatigue, headache, or gastrointestinal disturbances. In rare cases, allergic reactions, tremors, or confusion may occur, especially in elderly patients. Patients should avoid alcohol or other sedatives during treatment, as these may enhance drowsiness.
Patients should strictly follow their doctor’s instructions regarding dosage and treatment duration. It is also advised not to drive or operate heavy machinery while using this medication due to the risk of drowsiness.
General data about VERTIGIX 20mg / 40mg
- Substance:
- cinnarizine + dimenhydrinate
- Date of latest medicines list:
- 01-10-2026
- Product code:
- W64195001
- Strength:
- 20mg / 40mg
- Pharmaceutical form:
- tablets
- Quantity:
- 50
- Product type:
- Generic medicine
- Price:
- 57.55 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Official documents
Warnings:
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Glaucoma warning
Use caution if you have glaucoma or increased eye pressure.
Anticholinergic effects
May cause dry mouth, constipation, urinary retention, or blurred vision.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Reimbursement lists for VERTIGIX 20mg / 40mg Galenica
B - Sublist B with 50% discount from the reference price
- Price
- 57.55 RON
- Copayment
- 28.78 RON
- Patient payment
- 28.77 RON